Periodontal Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

 Periodontal Disease Market Outlook

Thelansis’s “Periodontal Disease Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Periodontal Disease treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

Periodontal Disease Overview

Periodontal disease activity is defined clinically by progressive loss of probing attachment and radiographically by progressive loss of alveolar bone. This disease, encompassing gingivitis, and periodontitis, exhibits high prevalence among adults, and its severity tends to increase with age. It is a bacterial infection primarily affecting the dental biofilm or plaque. Individual risk factors for periodontal disease can be categorized as follows: lifestyle factors such as gender, smoking, and alcohol; diabetes; obesity and metabolic syndrome; osteoporosis, dietary calcium, and vitamin D; stress; and genetic factors. The common signs and symptoms of periodontal disease include redness, swelling, and tenderness of the gums; bleeding during brushing and flossing; recession of the gums; loose or separating teeth; persistent halitosis; ill-fitting partial dentures; the presence of pus between the teeth and gums; and alterations in bite and jaw alignment. Periodontal disease is classified into different types based on disease stage, including gingivitis, mild periodontitis, and moderate to advanced periodontitis. Gingivitis represents the mildest form, characterized by red, swollen, and tender gums that bleed easily. Timely dental care and consistent home care can help resolve these issues. If left untreated, gingivitis progresses to mild periodontitis, where periodontal pockets form as the gums detach from the teeth, leading to early bone loss. Prompt dental intervention is necessary to prevent further bone erosion and gum damage. In the most advanced stage, moderate to advanced periodontitis, significant bone loss, deepening of periodontal pockets, and gum recession are observed. Extraction of teeth may be required due to tooth looseness. Treatment options for periodontal disease may include tartar and plaque removal below the gumline through deep cleaning (scaling and root planing), eliminating tartar and infected tissue in the early stages while smoothing damaged root surfaces to facilitate gum reattachment. Antibacterial medications can be applied topically in periodontal pockets or taken orally. In advanced cases, surgery may be necessary to clean infected areas beneath the gums and reshape or replace tissues.

 

Geography coverage:

G8 (United States, EU5 [France, Germany, Italy, Spain, U.K.], Japan, and China)

Insights driven by robust research, including:

• In-depth interviews with leading KOLs and payers
• Physician surveys
• RWE analysis for claims and EHR datasets
• Secondary research (e.g., peer-reviewed journal articles, third-party research databases)

Deliverables format and updates*:

• Detailed Report (PDF)
• Market Forecast Model (MS Excel-based automated dashboard)
• Epidemiology (MS Excel; interactive tool)
• Executive Insights (PowerPoint presentation)
• Others: regular updates, customizations, consultant support

*As per Thelansis’s policy, we ensure that we include all the recent updates before releasing the report content and market model.

Salient features of Market Forecast model:

• 10-year market forecast (2024–2034)
• Bottom-up patient-based market forecasts validated through the top-down sales methodology
• Covers clinically and commercially-relevant patient populations/ line of therapies
• Annualized drug-level sales and patient share projections
• Utilizes our proprietary Epilansis and Analog tool (e.g., drug uptake and erosion) datasets and conjoint analysis approach
• Detailed methodology/sources & assumptions
• Graphical and tabular outputs
• Users can customize the model based on requirements

Key business questions answered:

• How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)?
• How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments?
• What is the 10-year market outlook for sales and patient share?
• Which events will have the greatest impact on the market’s trajectory?
• What insights do interviewed experts provide on current and emerging treatments?
• Which pipeline products show the most promise, and what is their potential for launch and future positioning?
• What are the key unmet needs and KOL expectations for target profiles?
• What key regulatory and payer requirements must be met to secure drug approval and favorable market access?
• and more…

Read more: Periodontal Disease – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034